Results 111 to 120 of about 25,326 (255)
Uveal melanoma - a review of treatment methods
, 2023 Uveal melanoma is the most common primary intraocular malignancy. In Europe, the incidence of uveal melanoma is approximately 8 cases per million people per year. In about 50% of cases, uveal melanoma metastasizes.
Piekarz, Daria +4 more
core +1 more source
Cystoid macular edema as the initial manifestation of choroidal melanoma
Oman Journal of Ophthalmology, 2012 Uveal melanomas are a common clinical entity that initially present in a variety of ways. Cystoid macular edema is caused by many conditions, but it is rarely associated with uveal melanoma.
Robert B Garoon +3 more
doaj +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Yenny Angela +6 more
wiley +1 more source
Clinical and Radiometabolic Correlatives of ddPCR Liquid Biopsy for BRAF V600 Mutated Melanoma
International Journal of Cancer, Volume 159, Issue 4, Page 1068-1078, 15 August 2026.Commercial circulating tumor DNA (ctDNA) liquid biopsy tests are increasingly used for disease monitoring and surveillance in melanoma. However, data regarding the possible correlations between ctDNA and baseline clinical and radiometabolic parameters such as metastatic locations, tumor volume, and tumor glycolysis in patients with BRAF‐mutated ...
Ronen Stoff +8 more
wiley +1 more source
A Case of Uveal Melanoma with Liver Metastasis 6 Years after Enucleation of the Left Eye Ball
, 2009 In Europe and the United States, uveal melanoma involving the choroid membrane is the most commonlyoccurring intraocular malignancy in adults. Hepatic metastasis of uveral melanoma tends to have a poorprognosis.
Terauchi, Masaya +8 more
core
TCF/LEF family transcription factors: Molecular landscape and prognostic scoring in pan‐cancer
Clinical and Translational Discovery, Volume 6, Issue 4, August 2026.This study provides a comprehensive molecular landscape of TCF/LEF family transcription factors across 33 cancer types. We developed a TCF/LEF‐based prognostic score that correlates with immune infiltration, metabolic reprogramming and drug sensitivity, offering a robust transcriptomic signature for predicting patient survival and therapeutic response.
Zhengjun Yang +8 more
wiley +1 more source
Radiogenic side effects of 106 ru brachytherapy of uveal melanoma and its treatment
, 2018 One the most common primary tumors in the eye is uveal melanoma, that among other treatment of it brachytherapy with ru106 is most commonly recommend to the patients.
Ghafoorian Borojerdnia, Sara
core
Assessing Prognosis in Uveal Melanoma
, 2016 Because uveal melanoma is the most common primary malignant intraocular tumor in adults and carries a significant risk of metastases, which are mostly unresponsive to available systemic therapy, researchers have been searching for prognostic indicators ...
Zélia M. Corrêa, Correa, Zelia M
core +1 more source
Immunological profiling of uveal melanoma.
, 2019 A. Venn diagram showing the number of significantly modulated genes in GSE62075 overlapping the “Immune response” genes (GO:0006955); B. MHC class I gene expression in uveal melanoma as determined in GSE62075; C.
Teresio Avitabile (3854728) +11 more
core +1 more source
Updates on intratumoral therapies in melanoma
Cancer, Volume 132, Issue 13, 1 July 2026.Abstract Intratumoral therapies provide an opportunity for novel strategies in the management of advanced melanoma. These approaches deliver concentrated doses of therapeutic immune agents directly into individual tumor(s), achieving local tumor control and induction of systemic antitumor immune responses while minimizing the risk of immune‐related ...
Vincent T. Ma +12 more
wiley +1 more source